(DJAN) First Trust Exchange-Traded - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F6319

Stocks, Options, ETF, Investment, Securities

Description: DJAN First Trust Exchange-Traded

The First Trust Exchange-Traded Fund VIII - FT Cboe Vest U.S. Equity Deep Buffer ETF - January (DJAN) is an exchange-traded fund that invests primarily in FLexible EXchange Options (FLEX Options) referencing the SPDR S&P 500 ETF Trust. This investment strategy allows the fund to benefit from the performance of the S&P 500 index while potentially mitigating downside risk through the use of customized options contracts.

As a Defined Outcome ETF, DJAN is designed to provide a specific outcome, in this case, a deep buffer against losses in the underlying ETF. This means the fund aims to absorb a certain level of losses before they affect the investors returns, providing a level of protection. The funds non-diversified nature means it can invest a larger portion of its assets in a smaller number of holdings, which can increase the risk but also potentially the returns.

From a performance perspective, key performance indicators (KPIs) such as the funds tracking error, Sharpe ratio, and maximum drawdown can be crucial. The funds ability to achieve its stated objective of providing a buffer against losses can be evaluated by examining its historical performance during periods of market stress. Additionally, metrics like the funds expense ratio and trading volume can provide insights into its operational efficiency and liquidity.

With an Assets Under Management (AUM) of $357.77 million, DJAN has a considerable size that can contribute to liquidity and potentially lower trading costs for investors. However, the funds size and liquidity should be continuously monitored as they can impact the funds ability to achieve its investment objectives.

Investors should also consider the funds investment strategy and how it aligns with their overall investment goals and risk tolerance. The use of FLEX Options allows for customization, but it also introduces complexity and potential risks that need to be carefully managed.

Additional Sources for DJAN ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

DJAN ETF Overview

Market Cap in USD 346m
Category Defined Outcome
TER 0.85%
IPO / Inception 2021-01-15

DJAN ETF Ratings

Growth Rating 62.2
Fundamental -
Dividend Rating 0.0
Rel. Strength -6.81
Analysts -
Fair Price Momentum 38.37 USD
Fair Price DCF -

DJAN Dividends

Currently no dividends paid

DJAN Growth Ratios

Growth Correlation 3m 97.8%
Growth Correlation 12m 59.7%
Growth Correlation 5y 80.5%
CAGR 5y 6.98%
CAGR/Max DD 5y 0.73
Sharpe Ratio 12m 1.04
Alpha 0.41
Beta 0.391
Volatility 3.07%
Current Volume 8.9k
Average Volume 20d 12.2k
Stop Loss 39.7 (-3.1%)
What is the price of DJAN shares?
As of July 30, 2025, the stock is trading at USD 40.98 with a total of 8,867 shares traded.
Over the past week, the price has changed by +0.56%, over one month by +1.59%, over three months by +8.13% and over the past year by +10.03%.
Is First Trust Exchange-Traded a good stock to buy?
Yes. Based on ValueRay's Analyses, First Trust Exchange-Traded (BATS:DJAN) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.19 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DJAN is around 38.37 USD . This means that DJAN is currently overvalued and has a potential downside of -6.37%.
Is DJAN a buy, sell or hold?
First Trust Exchange-Traded has no consensus analysts rating.
What are the forecasts for DJAN share price target?
According to our own proprietary Forecast Model, DJAN First Trust Exchange-Traded will be worth about 43.1 in July 2026. The stock is currently trading at 40.98. This means that the stock has a potential upside of +5.25%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 43.1 5.2%